Krazati

Roche ESMO 2026
Biotech

ESMO: Roche touts ‘convincing’ KRAS data after phase 3 win

Roche has shed more light on its investigational KRAS G12C inhibitor’s phase 3 victory over Amgen’s Lumakras and Bristol Myers Squibb’s Krazati.
James Waldron Oct 25, 2026 11:30am
raised boxing glove with confetti falling around it

Roche orchestrates phase 3 lung cancer win over Amgen and BMS

Jul 2, 2026 8:30am
Combine

Kura posts data on drug designed to unleash KRAS inhibitors

May 26, 2026 10:09am
An artists impression of cancer cells The cancer cells are lavender on a yellow-gold background

Researchers find 'highly synergistic' pancreatic cancer combo

Jun 30, 2023 12:57pm
Graphic showing arrows missing the bullseye on a target

Mirati's wait for next lung cancer med ends in phase 3 failure

May 24, 2023 4:00pm
throw away trash garbage bin

Mirati eyes 'highest opportunity for capital' in pipeline build

Jan 9, 2023 1:37pm